Skip to main content
Equibles

Peter Mariani

CFO

Cytosorbents Corp (CTSO)

Equibles does not estimate personal net worth.

Get an email with a short summary when Cytosorbents Corp publishes a filing, an earnings call transcript or a press release.

Get CTSO alerts

About Peter Mariani

Peter Mariani is recorded as CFO at Cytosorbents Corp (CTSO). The proxy statement of Cytosorbents Corp reports total compensation of $659,872 for Peter Mariani in fiscal 2025, including a base salary of $442,000. Disclosed compensation is on record for 2 fiscal years. Peter Mariani has spoken on 8 earnings calls across 1 company, most recently for Cytosorbents Corp on November 12, 2026. Cytosorbents Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Cytosorbents Corp includes Phillip Chan (CEO and Board Member), Alexander D'Amico (CFO), Kathleen Bloch (CFO) and 7 others.

Peter Mariani on recent calls

“Joining me on today's call is Dr. Philip Chan, our Chief Executive Officer.”
CFO, Cytosorbents Corp Q3 FY2026 Earnings Call ·
“Joining me today is Dr. Philip Chan, our Chief Executive Officer, and Dr. Micah Esteli-Ageris, our Chief Medical Officer.”
CFO, Cytosorbents Corp Q1 FY2026 Earnings Call ·
“Joining me today is Dr. Philip Chan, our Chief Executive Officer. Before I turn the call over to Phil, I'd like to remind listeners that during the call, management's prepared remarks may contain forward-looking statements, which are subject to risks and uncertainties.”
CFO, Cytosorbents Corp Q4 FY2025 Earnings Call ·
“Today, I'll be reviewing our third quarter financial performance and important updates that strengthen our balance sheet and our outlook through 2026. First of all, revenue was $9.5 million, an increase of 10% and 4% on a constant currency basis compared to $8.6 million in the third quarter of 2024.”
CFO, Cytosorbents Corp Q3 FY2025 Earnings Call ·
“Today, I'll be reviewing our Q2 financial performance and sharing our outlook for the balance of 2025. Q2 revenue was $9.6 million, an increase of 9% and 4% on a constant currency basis compared to $8.8 million in Q2 of 2024.”
CFO, Cytosorbents Corp Q2 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Cytosorbents Corp

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Cytosorbents Corp (CTSO) $442,000 $659,872
2024 Cytosorbents Corp (CTSO) $152,019 $584,765

Recent activity